Glucobay M - Evaluation of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice
Latest Information Update: 13 Nov 2019
At a glance
- Drugs Acarbose/metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms GLORY
- Sponsors Bayer
- 22 Mar 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
- 24 Feb 2015 Planned End Date changed from 1 Sep 2016 to 1 Mar 2017 as reported by ClinicalTrials.gov
- 24 Feb 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov